Risk of Malignancy in Sonographically Confirmed Ovarian Tumors

2012/02/18 by Rachel W. Miller, Frederick R. Ueland · 1 citation
Medicine · #Ovarian cancer diagnosis and treatment #Endometrial and Cervical Cancer Treatments #Intraperitoneal and Appendiceal Malignancies #Medicine #Malignancy #Asymptomatic #Ovarian cancer #Referral #Gynecologic oncology #Gynecology #Radiology #Cancer #Oncology #Internal medicine

paper · doi:10.1097/grf.0b013e31824970cf

openalex publication_date 2012/02/18 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/25

Abstract

Ovarian cancer is the leading cause of gynecologic cancer death in the United States. Once an ovarian tumor is identified, a pelvic ultrasound is recommended, including tumor volume and tumor structure. Unilocular and simple septate tumors are unlikely to be malignant and when asymptomatic, can be safely followed conservatively without surgery. Complex ovarian tumors are at an increased risk for malignancy and secondary testing is recommended. Secondary testing may include CA125, OVA1, the RMI, ROMA, or the ACOG referral guidelines. When secondary testing indicates that an ovarian tumor is at high risk for malignancy, referral to a gynecologic oncologist is recommended.

Cited by

• Ovarian cancer [wikipedia]

Related

• Simple ultrasound‐based rules for the diagnosis of ovarian cancer
• Ovarian cancer prediction in adnexal masses using ultrasound‐based logistic regression models: a temporal and external validation study by the IOTA group
• Screening for Ovarian Cancer
• Intra‐ and interobserver agreement when describing adnexal masses using the International Ovarian Tumor Analysis terms and definitions: a study on three‐dimensional ultrasound volumes
• The Accuracy of Risk Scores in Predicting Ovarian Malignancy